Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Hormone receptor positive HER2 negative breast cancer

Recruiting

Registered drugNo placebo

Study of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing

Registered drugNo placebo

France

Participants:18–64 years
Substances:Anastrozole

Contact Research Centre

HER2 positive breast cancer

Recruiting

Registered drugNo placebo

Study of Trastuzumab Deruxtecan and Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer Who Have Not Received Prior Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pertuzumab

Contact Research Centre

Sepsis

Recruiting

Registered drugNo placebo

Testing a Drug Combination for Personalized Sepsis Treatment in Children and Adults with Severe Blood Infection

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Anakinra

Contact Research Centre

Acute respiratory failure

Recruiting

Registered drugNo placebo

Study of High-Flow Nasal Oxygen During Intubation in Intensive Care Patients with Low Blood Oxygen Levels

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Oxygen

Contact Research Centre

Plasma cell myeloma

Recruiting

Registered drugNo placebo

Study of elranatamab and lenalidomide combination versus standard chemotherapy and transplant in newly diagnosed multiple myeloma patients

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Study on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Plasma cell myeloma recurrent

Recruiting

Registered drugNo placebo

Study Comparing Continuous and Fixed Duration Therapy with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Relapsed Multiple Myeloma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Acute respiratory failure

Recruiting

Registered drugNo placebo

Study on Weaning Patients with Acute Respiratory Failure from High-Flow Nasal Oxygen Therapy Using Oxygen

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Oxygen

Contact Research Centre

Obesity

Recruiting

Registered drugNo placebo

Study on Vitamin D Deficiency Treatment in Obese Children and Adolescents Using Colecalciferol: Comparing Monthly Boluses and Daily Doses

Registered drugNo placebo

France

Participants:0–17 years
Substances:Colecalciferol

Contact Research Centre

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Recruiting

Registered drugNo placebo

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

HER2 positive breast cancer

Recruiting

Registered drugNo placebo

Study on Reducing Treatment for Patients with HER2-Positive Metastatic Breast Cancer Using Trastuzumab and Drug Combination After 2 Years of Controlled Disease

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pertuzumab

Contact Research Centre

Efficacy of dapagliflozin in adult patients with septic shock and microcirculatory dysfunction

Not yet recruiting

Registered drug

Efficacy of dapagliflozin in adult patients with septic shock and microcirculatory dysfunction

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Dapagliflozin

Contact Research Centre

Find therapies in clinical trials near you

29 trials match your criteria

Hormone receptor positive HER2 negative breast cancer

Study of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing

HER2 positive breast cancer

Study of Trastuzumab Deruxtecan and Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer Who Have Not Received Prior Treatment

Sepsis

Testing a Drug Combination for Personalized Sepsis Treatment in Children and Adults with Severe Blood Infection

Acute respiratory failure

Study of High-Flow Nasal Oxygen During Intubation in Intensive Care Patients with Low Blood Oxygen Levels

Plasma cell myeloma

Study of elranatamab and lenalidomide combination versus standard chemotherapy and transplant in newly diagnosed multiple myeloma patients

Triple negative breast cancer

Study on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment

Plasma cell myeloma recurrent

Study Comparing Continuous and Fixed Duration Therapy with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Relapsed Multiple Myeloma

Acute respiratory failure

Study on Weaning Patients with Acute Respiratory Failure from High-Flow Nasal Oxygen Therapy Using Oxygen

Obesity

Study on Vitamin D Deficiency Treatment in Obese Children and Adolescents Using Colecalciferol: Comparing Monthly Boluses and Daily Doses

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

HER2 positive breast cancer

Study on Reducing Treatment for Patients with HER2-Positive Metastatic Breast Cancer Using Trastuzumab and Drug Combination After 2 Years of Controlled Disease

Efficacy of dapagliflozin in adult patients with septic shock and microcirculatory dysfunction

Efficacy of dapagliflozin in adult patients with septic shock and microcirculatory dysfunction

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.